Using lipidomics and proteomics to find biomarkers that predict progression of multiple sclerosis

Project Details

This study, in collaboration with the Baker Institute and Walter and Eliza Hall Institute, will examine in a longitudinal study blood samples from people with MS and matched controls, looking for novel lipid and protein biomarkers that can predict the progression of MS.

Identifying such biomarkers is critical to enable appropriate targeting of expensive and potentially toxic pharmaceuticals and invasive medical procedures such as autologous haematopoietic stem cell transplantation to those people with MS whose disease is likely to progress rapidly.

Researchers

Dr Alysha De Livera

Collaborators

Dr Peter Meikle, Baker Institute
Dr Andrew Webb, Walter and Eliza Hall Institute

Research Group

Neuroepidemiology



Faculty Research Themes

Neuroscience

School Research Themes

Prevention and management of non-communicable diseases (including cancer), and promotion of mental health



Key Contact

For further information about this research, please contact the research group leader.

Department / Centre

Centre for Epidemiology and Biostatistics